Physician profile
Marci Cunningham
NPI 1417315839
$2,831.70
in general payments reported to CMS, 2019-2025
20 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,289 · 2022: $507 · 2023: $458 · 2024: $243 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,456.16 | 2021-2024 | |
| Abbvie INC. | $258.34 | 2023-2025 | |
| Kerecis Limited | $145.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Endo Pharmaceuticals INC. | $129.95 | 2021-2024 | Xiaflex |
| Regeneron Healthcare Solutions, INC. | $128.21 | 2021 | |
| Mentor Worldwide LLC | $126.14 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Novo Nordisk INC | $96.75 | 2025 | Wegovy |
| Endo USA, INC. | $96.19 | 2024-2025 | Xiaflex |
| Integra Lifesciences Corporation | $59.10 | 2023 | Durasorb Monofilament Mesh, Tenoglide |
| Lilly USA, LLC | $53.49 | 2025 | Zepbound |
| Stryker Corporation | $50.59 | 2024 | Scopis Ent |
| Currax Pharmaceuticals LLC | $46.84 | 2025 | Contrave |
| Acclarent, INC | $35.38 | 2022 | |
| Davol INC. | $32.27 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.33 | 2022-2023 | Seglentis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21.00 | 2024 | Wavewriter Alpha Prime 16 |
| Intersect Ent, INC. | $18.54 | 2021 | |
| Tela Bio, INC. | $17.50 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Actelion Pharmaceuticals US, INC. | $16.68 | 2024 | Opsumit, Uptravi |
| Hologic Sales and Service, LLC | $15.78 | 2023 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marci Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.